4//SEC Filing
Aclaris Therapeutics, Inc. 4
Accession 0001209191-17-040674
$ACRSCIK 0001557746operating
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 7:46 PM ET
Size
5.3 KB
Accession
0001209191-17-040674
Insider Transaction Report
Form 4
Bierly Rick
Director
Transactions
- Award
Stock Option (right to buy)
2017-06-15+8,000→ 8,000 totalExercise: $24.58Exp: 2027-06-14→ Common Stock (8,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest in twelve equal monthly installments through June 15, 2018, subject to the reporting person's continuous service as of such vesting date.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001557746
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 7:46 PM ET
- Size
- 5.3 KB